Literature DB >> 24790676

Liver involvement in patients with systemic autoimmune diseases.

Manole Cojocaru1, Inimioara Mihaela Cojocaru2, Isabela Silosi3, Camelia Doina Vrabie4.   

Abstract

ABSTRACT: A wide variety of systemic autoimmune diseases (SAD) affects the liver, and various forms of hepatic involvement have been reported. Patients who have SAD, the abnormal liver function tests might be caused by SAD. In most of these patients, SAD should be treated primary. Liver involvement in SAD is a matter of great clinical challenge evoking several questions upon diagnostic criteria for liver diseases and the presence of overlap syndromes. This review will describe liver injury caused by various systemic autoimmune diseases.

Entities:  

Keywords:  laboratory tests; liver; systemic autoimmune diseases

Year:  2013        PMID： 24790676      PMCID： PMC3968480     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN： 1841-9038


  20 in total

Review 1.  Hepatic manifestations of autoimmune rheumatic diseases.

Authors:  S Abraham; S Begum; D Isenberg
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

2.  Hepatic manifestations of autoimmune rheumatic diseases.

Authors:  V Sandhu; A S M Jawad
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

3.  [Adult-onset Kawasaki syndrome in the differential diagnosis of liver disease].

Authors:  Z Péter; G Prinz; J Schuller; K Szalman; L Telegdy
Journal:  Orv Hetil       Date:  2001-07-08       Impact factor: 0.540

4.  Lupus-related advanced liver involvement as the initial presentation of systemic lupus erythematosus.

Authors:  Ming-Chi Lu; Ko-Jen Li; Song-Chou Hsieh; Cheng-Han Wu; Chia-Li Yu
Journal:  J Microbiol Immunol Infect       Date:  2006-12       Impact factor: 4.399

5.  Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.

Authors:  J R Curtis; T Beukelman; A Onofrei; S Cassell; J D Greenberg; A Kavanaugh; G Reed; V Strand; J M Kremer
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

6.  Clinical features of liver disturbance in rheumatoid diseases: clinicopathological study with special reference to the cause of liver disturbance.

Authors:  Hideyuki Kojima; Masahito Uemura; Shinya Sakurai; Tatsuichi Ann; Yoshinobu Ishii; Hiroo Imazu; Masahide Yoshikawa; Kunio Ichijima; Hiroshi Fukui
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

7.  Autoimmune hepatitis accompanied by systemic lupus erythematosus.

Authors:  Jun Tojo; Hiromasa Ohira; Kazumichi Abe; Junko Yokokawa; Junko Takiguchi; Tsuyoshi Rai; Shoichiro Shishido; Yukio Sato; Reiji Kasukawa
Journal:  Intern Med       Date:  2004-03       Impact factor: 1.271

Review 8.  [The liver and methotrexate].

Authors:  D Laharie; E Terrebonne; J Vergniol; E Chanteloup; E Chabrun; P Couzigou; V de Lédinghen
Journal:  Gastroenterol Clin Biol       Date:  2008-02

Review 9.  Liver abnormalities in rheumatic diseases.

Authors:  Nancy J Walker; Robert B Zurier
Journal:  Clin Liver Dis       Date:  2002-11       Impact factor: 6.126

10.  Leflunomide for the treatment of rheumatoid arthritis in clinical practice: incidence and severity of hepatotoxicity.

Authors:  Eric N van Roon; Tim L Th A Jansen; Nella M Houtman; Piet Spoelstra; Jacobus R B J Brouwers
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606
View more
  3 in total

Review 1.  Clinical connection between rheumatoid arthritis and liver damage.

Authors:  Biljana Radovanović-Dinić; Snežana Tešić-Rajković; Valentina Zivkovic; Saša Grgov
Journal:  Rheumatol Int       Date:  2018-04-07       Impact factor: 2.631

2.  Anti-inflammatory and Hepatoprotective Effects of Quercetin in an Experimental Model of Rheumatoid Arthritis.

Authors:  Ana Carolina de Figueiredo Costa; Luane Macedo de Sousa; Joana Maria Dos Santos Alves; Paula Goes; Karuza Maria Alves Pereira; Ana Paula Negreiros Nunes Alves; Mariana Lima Vale; Delane Viana Gondim
Journal:  Inflammation       Date:  2021-06-02       Impact factor: 4.092

3.  Characterization of the Effect of Hepatic Impairment on Upadacitinib Pharmacokinetics.

Authors:  Sheryl Trueman; Mohamed-Eslam F Mohamed; Tian Feng; Ana Paula Lacerda; Thomas Marbury; Ahmed A Othman
Journal:  J Clin Pharmacol       Date:  2019-04-11       Impact factor: 3.126
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.